Clinical Trials Sponsored by Cutera Inc.
Total 36105 results
-
Natera, Inc.CompletedConcurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD) (IVF008)Any Single Gene Disorder (Cystic Fibrosis, Tay-Sachs)United States
-
Natera, Inc.CompletedSex Chromosome Aberrations | Chromosome 13 Aneuploidy | Chromosome 18 Aneuploidy | Chromosome 21 Aneuploidy | Other MicrodeletionsUnited States
-
Natera, Inc.Not yet recruitingHeart Transplant Failure and Rejection
-
Natera, Inc.RecruitingComplications | Transplant Rejection | Allograft RejectionUnited States
-
Natera, Inc.Active, not recruitingHeart Transplant RejectionUnited States
-
Natera, Inc.CompletedTrisomy 21 | Trisomy 18 | Trisomy 13 | Vanishing TwinUnited States
-
Natera, Inc.CompletedTrisomy 21 | Trisomy 18 | Trisomy 13 | Sex Chromosome Abnormalities | Microdeletion SyndromesUnited States
-
Natera, Inc.CompletedPregnancy Following IVF With PGS/PGDUnited States
-
Natera, Inc.RecruitingPregnancy Complications | Twin to Twin Transfusion Syndrome | Multiple Gestation; Maternal CareUnited States
-
Natera, Inc.Active, not recruiting
-
Natera, Inc.Active, not recruitingKidney DiseasesUnited States
-
Natera, Inc.WithdrawnGenetic Testing | Spinal Muscular Atrophy (SMA) | Carrier ScreeningUnited States
-
Natera, Inc.CompletedSingle Gene DisordersUnited States
-
Cothera Bioscience, IncRecruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene RearrangementKorea, Republic of, China
-
OcuTerra Therapeutics, Inc.CompletedAge-Related Macular DegenerationUnited States
-
OcuTerra Therapeutics, Inc.CompletedDiabetic Macular EdemaUnited States
-
Cohera Medical, Inc.TerminatedColorectal and Ileorectal Anastomosis | Colocolic and Ileocolic Anastomosis | Coloanal and Ileoanal AnastomosisUnited States
-
Cohera Medical, Inc.TerminatedColorectal and Ileorectal AnastomosisNetherlands
-
Entera Health, IncCompletedHIV-associated EnteropathyUnited States
-
Entera Health, IncCompleted
-
Cohera Medical, Inc.CompletedDisorder of Skin and/or Subcutaneous Tissue of TrunkUnited States
-
Cohera Medical, Inc.Completed
-
Sotera Wireless, Inc.UnknownSleep Apnea, ObstructiveUnited States
-
Cohera Medical, Inc.CompletedAbdominoplastyGermany
-
Cohera Medical, Inc.Completed
-
Cohera Medical, Inc.Completed
-
Cohera Medical, Inc.CompletedDeep Inferior Epigastric Perforator Flap Reconstruction
-
Entera Health, IncTerminatedCrohn's DiseaseUnited States
-
Entera Health, IncCompletedDiarrhoea Predominant Irritable Bowel SyndromeUnited States
-
Sotera Wireless, Inc.Withdrawn
-
UNICANCERNatera, Inc.Not yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer
-
Cohera Medical, Inc.Completed
-
Sotera Wireless, Inc.WithdrawnHypertension | HypotensionUnited States
-
OcuTerra Therapeutics, Inc.ParexelCompleted
-
Natera, Inc.Ferring PharmaceuticalsTerminatedIn Vitro Fertilization (IVF) | Preimplantation Genetic Diagnosis (PGD) | Preimplantation Gentic Screening (PGS)United States
-
Georgetown UniversityGenentech, Inc.; Natera, Inc.RecruitingHepatocellular Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Rectal Adenocarcinoma | Colon Adenocarcinoma | Gallbladder Adenocarcinoma | Adenocarcinoma of Biliary TractUnited States
-
University of OklahomaNatera, Inc.RecruitingPancreas CancerUnited States
-
Mayo ClinicEntera Health, IncTerminatedMultiple MyelomaUnited States
-
Natera, Inc.University of MarylandRecruitingKidney Transplant RejectionUnited States
-
Northwestern UniversityEntera Health, IncTerminatedClostridium DifficileUnited States
-
Qure Healthcare, LLCNatera, Inc.CompletedTransplant;Failure,KidneyUnited States
-
University of FloridaNatera, Inc.Active, not recruitingMetastatic Colorectal CancerUnited States
-
Jason K Rivers, MD, FRCPC, FAADCutera Inc.Completed
-
NSABP Foundation IncNovartis Pharmaceuticals; Natera, Inc.Withdrawn
-
OHSU Knight Cancer InstituteNatera, Inc.RecruitingEstablishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8United States
-
Inova Health Care ServicesNatera, Inc.WithdrawnPancreatic CancerUnited States